NASDAQ: CHRS
Coherus Oncology Inc Stock Ownership - Who owns Coherus Oncology?

Insider buying vs selling

Have Coherus Oncology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Dennis M. LanfearPresident CEO2026-01-2011,839$1.55
$18.35kSell
Bryan J. McMichaelChief Financial Officer2026-01-201,715$1.55
$2.66kSell
Mats WahlstromDirector2025-05-2399,988$0.74
$73.89kSell

1 of 1

CHRS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CHRS insiders and whales buy or sell their stock.

CHRS Shareholders

What type of owners hold Coherus Oncology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc7.05%10,562,709$18.27MInstitution
Vanguard Group Inc6.69%10,028,893$17.35MInstitution
Vsciences Investments Pte Ltd4.92%7,381,116$12.77MInsider
Lilly Co Eli2.03%3,042,019$5.26MInsider
Kohlberg Kravis Roberts Co LP2.03%3,036,076$5.25MInstitution
Dennis M. Lanfear1.95%2,926,612$5.06MInsider
Daiichi Sankyo Company Ltd1.91%2,867,426$4.96MInsider
Geode Capital Management LLC1.83%2,745,246$4.75MInstitution
Tang Capital Management LLC1.82%2,724,509$4.71MInstitution
Kkr Biosimilar LP1.67%2,499,499$4.32MInsider

1 of 3

CHRS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CHRS34.23%14.29%Net SellingNet Selling
ALXO22.19%11.13%Net BuyingNet Buying
TENX40.48%46.56%Net Buying
EDIT51.02%33.67%Net SellingNet Selling
HELP60.30%0.00%

Coherus Oncology Stock Ownership FAQ

Who owns Coherus Oncology?

Coherus Oncology (NASDAQ: CHRS) is owned by 34.23% institutional shareholders, 14.29% Coherus Oncology insiders, and 51.48% retail investors. Vsciences Investments Pte Ltd is the largest individual Coherus Oncology shareholder, owning 7.38M shares representing 4.92% of the company. Vsciences Investments Pte Ltd's Coherus Oncology shares are currently valued at $12.77M.

If you're new to stock investing, here's how to buy Coherus Oncology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.